Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
9.51
+0.22 (2.37%)
At close: Apr 28, 2026, 4:00 PM EDT
9.50
-0.01 (-0.11%)
After-hours: Apr 28, 2026, 4:32 PM EDT
Upstream Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Upstream Bio stock have an average target of 37.67, with a low estimate of 15 and a high estimate of 51. The average target predicts an increase of 296.11% from the current stock price of 9.51.
Analyst Consensus: Buy
* Price targets were last updated on Mar 27, 2026.
Analyst Ratings
The average analyst rating for Upstream Bio stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $40 → $15 | Buy → Hold | Downgrades | $40 → $15 | +57.73% | Mar 27, 2026 |
| Mizuho | Mizuho | Buy Initiates $51 | Buy | Initiates | $51 | +436.28% | Dec 18, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $40 | Buy | Initiates | $40 | +320.61% | Nov 18, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +394.22% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +299.58% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
1.51M
from 2.85M
Decreased by -47.20%
Revenue Next Year
1.27M
from 1.51M
Decreased by -16.06%
EPS This Year
-3.00
from -2.66
EPS Next Year
-3.24
from -3.00
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 4.2M | 3.0M | ||||||
| Avg | 1.5M | 1.3M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 47.2% | 101.4% | ||||||
| Avg | -47.2% | -16.1% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.45 | -2.17 | ||||||
| Avg | -3.00 | -3.24 | ||||||
| Low | -3.60 | -3.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.